This trial is completed!
Search for a recruiting clinical trial for your condition
You can access this
clinical trial
if you have
Disorder of Immune Function
and you are
over 65
years old
Phase
1
This is an early phase trial to determine
the dosage and safety of the new treatment.
Show me locations

The purpose

Background: Zinc supplementation has the potential to improve serum zinc levels and immunity of zinc deficient nursing home elderly. Objective: To determine the effect of zinc supplementation of 30mg/d for 3 months on serum zinc levels and T-cell mediated function of zinc deficient nursing home elderly. Design: This is a randomized, double-blind, placebo-controlled study. Outcome measures included change in serum zinc levels and various T-cell mediated immune factors between baseline and month 3. Hypotheses: The investigators hypothesize that zinc supplementation of 30mg/d for 3 months will improve serum zinc levels as well as various T-cell mediated immune factors in zinc deficient nursing home elderly.

Provided treatments

  • Other: zinc supplementation
Tris trial is registered with FDA with number: NCT01599572. The sponsor of the trial is Tufts University and it is looking for 31 volunteers for the current phase.
Official trial title:
Zinc Intervention in Nursing Home Elderly